1 Min Read
Dec 27 (Reuters) - Noxopharm Ltd:
* KAZIA THERAPEUTICS AND NOXOPHARM LIMITED ANNOUNCE COLLABORATION TO SUPPORT DEVELOPMENT OF NOXOPHARM LEAD PROGRAM, NOX66. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.